Indivior Inc.   Report issue

Founded: Richmond VA United States (2014)

Organization Overview

First Clinical Trial
2014
NCT00279565
First Marketed Drug
2014
buprenorphine
First NDA Approval
None
Last Known Activity
2022

Timeline

NOW
  • Now

Alternative names

Indivior Inc. | INDIVIOR INC | Indivior, PLC.